A Performance Test Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs; Extension of Comment Period

---
identifier: "/us/fr/2017-11292"
source: "fr"
legal_status: "authoritative_unofficial"
title: "A Performance Test Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs; Extension of Comment Period"
title_number: 0
title_name: "Federal Register"
section_number: "2017-11292"
section_name: "A Performance Test Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs; Extension of Comment Period"
positive_law: false
currency: "2017-06-01"
last_updated: "2017-06-01"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2017-11292"
document_type: "notice"
publication_date: "2017-06-01"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "82 FR 25289"
fr_volume: 82
docket_ids:
  - "CDC-2016-0090"
  - "Docket Number NIOSH 288-A"
fr_action: "Notice and extension of comment period."
---


#  A Performance Test Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs; Extension of Comment Period

**AGENCY:**

National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease  Control and Prevention (CDC), Department of Health and Human Services (HHS).

**ACTION:**

Notice and extension of comment period.

**SUMMARY:**

On September 15, 2016 the National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), published a notice in the *Federal Register* announcing a public meeting and request for public comment on a draft testing protocol.

Written comments were to be received by December 7, 2016. NIOSH initially extended the public comment period to June 7, 2017 [81 FR 88687]. NIOSH is extending the public comment period for a second time to August 30, 2017. The longer timeframe will allow companies to test the protocol with the proposed challenge agents.

**FOR FURTHER INFORMATION CONTACT:**

Deborah V. Hirst, NIOSH, Alice Hamilton Laboratories, 1090 Tusculum Avenue, MS-R-5, Cincinnati, Ohio 45226, telephone (513) 841-4141 (not a toll free number), Email: *[email protected].*

**ADDRESSES:**

You may submit comments, identified by CDC-2016-0090 and Docket Number NIOSH 288-A, by either of the following two methods:

• *Federal eRulemaking Portal: http://www.regulations.gov.* Follow the instructions for submitting comments.

• *Mail:* National Institute for Occupational Safety and Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C-34, Cincinnati, Ohio 45226-1998.

John Howard,

Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention.